MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
7.38
-0.05 (-0.67%)
Apr 15, 2025, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $246.67 million as of April 15, 2025.
Market Cap
246.67M
Enterprise Value
-15.31M
1-Year Change
n/a
Ranking
Category
Stock Price
7.38
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $246.67M, a decrease of -51.60%. That is a compound annual growth rate of -71.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2025 | 248.34M | -59.68% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |
| Thermo Fisher Scientific | 165.40B |
| Danaher | 135.03B |
| Stryker | 133.70B |
| Sanofi | 124.23B |
| Medtronic | 106.32B |
| McKesson | 86.39B |